A Study of the Safety of Rabeprazole Administered to Adults With Gastroesophageal Reflux Disease (GERD)
Clinical trial NCT00216489 · COMPLETED
Trial details
- NCT number
- NCT00216489
- Sponsor
- Janssen Cilag Pharmaceutica S.A.C.I., Greece
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-03-01
- Enrollment
- 191
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.